Customize your JAMA Network experience by selecting one or more topics from the list below.
The US Pharmacopeia (USP) has ceased operating its Drug Product Problem Reporting Program, which enabled pharmacists and other health care professionals to report drug quality problems "so that its efforts an resources may be concentrated on medication error reporting and prevention." The FDA wishes to encourage those who used the USP program to report product quality problems as well as adverse medical events to MEDWATCH by phone ( FDA-1088), fax ( FDA-0178), mail (MEDWATCH, FDA, HF-2, 5600 Fishers Ln, Rockville, MD 20857), or online (http://www.accessdata.fda.gov/scripts/medwatch).
Henney JE. Drug Product Problem Reports. JAMA. 2000;284(21):2711. doi:10.1001/jama.284.21.2711-JFD00010-4-1
Coronavirus Resource Center
Create a personal account or sign in to: